BioSystem Development, LLC., a Madison, WI-based life science analytics company, has completed an over $1.4m investment round in capital equipment and funding.
Two strategic manufacturing partners, All Metal Stamping and Orbital Biosciences, contributed $350,000 to the round in the form of tooling and manufacturing infrastructure. The remaining investment of just over $1.0m was contributed by current investors including groups from Marshfield Investment Partners, Silicon Pastures, Chippewa Valley Angel Investors Network, other individuals and several new contributors.
The company creates, manufactures and markets the AssayMAP™ Bioanalysis System, which is an open platform designed to improve the analytical workflows of biopharmaceutical process development.
As stated by Scott Fulton, Founder and Chief Executive Officer of BioSystem Development, the funding will support the company in formalizing key strategic technology and commercial partnerships as well as launch several new AssayMAP products.